药师参与精神分裂症患者随访对其用药依从性的影响调查  

Investigation of Effects of Pharmacists Participating in the Follow-up of Schizophrenia Patients on Compliance of Patients

作　　者：王彬[1] 杨开波[1] 

机构地区：[1]四川攀枝花市第三人民医院,四川攀枝花617061

出　　处：《中国药房》2012年第4期297-298,共2页China Pharmacy

摘　　要：目的:探讨药师参与精神分裂症患者随访对其用药依从性的影响。方法:采用电话随访形式对68例精神病患者的家属或患者进行调查。结果:第1次随访服药依从性平均仅为52.94%;经干预后第2次随访服药依从性提高到67.74%。2次随访服药依从性比较差异有统计学意义(P<0.05);因畏惧出现不良反应而不敢服药是依从性差的主要原因,依从性好的患者症状控制较好,依从性差的患者症状控制较差,且病情波动大。结论:精神病患者药物治疗依从性的影响因素较多,开展药学服务普及用药知识等,有利于提高用药依从性。OBJECTIVE： To explore the influence of schizophrenia patient＇ s compliance by pharmacists participated in the fol- low-up. METHODS： Using the telephone, we visited with 68 psychopath examples and the family members. RESULTS： The com- pliance of patients was only 52.94% at 1st following-up; increasing to 67.74% after intervention. There was significant difference between 2 following-up （P〈0.05）. Because of afraid of ADR was the main reason why the patients didn＇t obedience; the symp- toms of patients with good compliance were control well, the symptoms of patients with good compliance were badly controlled, and fluctuation was in a big way. CONCLUSIONS： There are many influencing factors for compliance of schizophrenia patients. The development of pharmaceutical care, popularization of medication knowledge and other methods are advantageous to enhance the compliance.

关 键 词：药师 精神分裂症患者 随访 依从性 

分 类 号：R95[医药卫生—药学]